Kansas City, MO, United States of America

Douglas J Bosma

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Synexis LLC, Lee Antimicrobial Solutions LLC. Active years: 2015-2025.

USPTO Granted Patents = 13 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Kansas City, MO (US) (2018 - 2021)
  • Armonk, NY (US) (2015 - 2023)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Journey of Douglas J Bosma

Introduction: Douglas J Bosma, a talented inventor hailing from Kansas City, MO (US), has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Douglas J Bosma holds several patents in various fields, including technology, engineering, and healthcare. His recent patents focus on improving efficiency in renewable energy systems and enhancing user experience in digital platforms.

Career Highlights: With a background in mechanical engineering, Douglas J Bosma has worked for leading tech companies where he honed his skills in product development and innovation. Throughout his career, he has been recognized for his out-of-the-box thinking and ability to turn ideas into reality.

Collaborations: Douglas J Bosma has collaborated with top researchers, engineers, and designers to bring his inventions to life. His collaborative spirit and passion for innovation have led to successful projects that have made a positive impact on industries worldwide.

Conclusion: In conclusion, Douglas J Bosma stands as a testament to the power of innovation and perseverance. His journey as an inventor continues to inspire aspiring innovators to push the boundaries of what is possible and create a better future for all.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…